Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2003
04/10/2003WO2003028696A2 Compositions for delivery of drug combinations
04/10/2003WO2003028661A2 Adjuvanted meningococcus compositions
04/10/2003WO2003028656A2 Adjuvant compositions
04/10/2003WO2003028652A2 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003WO2003028642A2 Methods of inhibiting metastases
04/10/2003WO2003028634A2 Method of treatment using ligand-immunogen conjugates
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/10/2003WO2003028473A1 Process for the fractionation of oilseed press cakes and meals
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity
04/10/2003WO2003007971A9 Improved heteropolymer complexes and methods for their use
04/10/2003WO2003004527A3 Novel neurotrophic factors
04/10/2003WO2003002598A3 Peptides for use as translocation factors
04/10/2003WO2003002092A3 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
04/10/2003WO2003000709A9 Sialic acid derivatives for use as siglec inhibitors
04/10/2003WO2003000118A3 Method for enhancing the effectiveness of cancer therapies
04/10/2003WO2002102978A3 Human growth hormone antagonists
04/10/2003WO2002102768A3 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
04/10/2003WO2002102394A3 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
04/10/2003WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
04/10/2003WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2003WO2002094189A3 Compositions and methods for treating or preventing convulsions or seizures
04/10/2003WO2002081668A8 Desaturase genes and uses thereof
04/10/2003WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors
04/10/2003WO2002076472A3 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
04/10/2003WO2002071827A3 Retinoid x receptor modulators
04/10/2003WO2002065988A3 Terminally-branched polymeric linkers and polymeric conjugates containing the same
04/10/2003WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery
04/10/2003WO2002059083A3 Novel compounds
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002055688A3 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
04/10/2003WO2002055095A8 Use of aziridino-compounds in the treatment of immune dysfunctions
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002036135A3 Compositions for antitumour treatment containing ecteinascidin 743
04/10/2003WO2002030920A1 Benzimidazole compounds, process for producing the same and use thereof
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer
04/10/2003WO2001087295A8 Methods for decreasing cell proliferation based on (3r, 4r)-δ8-tetrahydrocannabinol-11-oic acids
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069428 Pharmaceutically active isoindoline derivatives
04/10/2003US20030069419 Method for producing 1-substituted-1,2,3- triazole derivative
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069393 Compound for use in the treatment of cancer and prevention of infections
04/10/2003US20030069303 Osteoporosis, postmenopause
04/10/2003US20030069301 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
04/10/2003US20030069298 Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069294 Alpha-substituted carboxylic acid derivatives
04/10/2003US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069270 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxImic acid derivative
04/10/2003US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
04/10/2003US20030069259 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
04/10/2003US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/10/2003US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents
04/10/2003US20030069229 Methods of inhibiting metastases
04/10/2003US20030069228 Capase inhibitors; antiinflammatory agents
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate.
04/10/2003US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
04/10/2003US20030069200 Use of glucosylceramide synthesis inhibitors in brain cancertherapy
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069183 Lyophilized HGF preparations
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030068678 WISP polypeptides and nucleic acids encoding same
04/10/2003US20030068664 Monitoring effectiveness of preferential cancer immunotherapy; obtain mammal, administer immunotherapy, evaluate effectiveness of treatment
04/10/2003US20030068636 Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
04/10/2003US20030068429 Inulin products with improved nutritional properties
04/10/2003US20030068337 Composition comprising tumor cells and extracts and method using thereof
04/10/2003US20030068328 Live attenuated salmonella strains for producing monovalent or multivalent vaccines
04/10/2003US20030068298 Cytokine immunotherapy followed by neurosurgical intervention for total resection of intracerebral tumor; cytokine therapy comprises intravenous administration of lymphokine-activated killer cells with recombinant yeast interleukin-2
04/10/2003US20030068280 Treatment of respiratory diseases
04/10/2003CA2463404A1 Fragements of heat shock proteins and their use
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462790A1 Ul16 binding protein 4
04/10/2003CA2462675A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/10/2003CA2462602A1 Double stranded rna as an adjuvant in vaccine compositions
04/10/2003CA2462594A1 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003CA2462538A1 Process for the fractionation of oilseed press cakes and meals
04/10/2003CA2462425A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
04/10/2003CA2462259A1 Mammalian cell-infecting virus vector encoding epitope-bound .beta.2m and utilization thereof
04/10/2003CA2462144A1 Micro-rna molecules
04/10/2003CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003CA2461928A1 Solvent extraction process
04/10/2003CA2461905A1 Combined compositions and methods for tumor vasculature coagulation and treatment
04/10/2003CA2461877A1 Method of treatment using ligand-immunogen conjugates
04/10/2003CA2461292A1 Apo-2 ligand variants and uses thereof
04/10/2003CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
04/10/2003CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/10/2003CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003CA2460909A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds
04/10/2003CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003CA2460006A1 Methods and compositions for treating or preventing bacterial infection
04/10/2003CA2459194A1 Method for predicting the sensitivity to chemotherapy
04/10/2003CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003CA2455225A1 Novel proteins and nucleic acids encoding same
1 ... 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 ... 2211